Preliminary 6-month results from DIAGNODE-1 before Christmas
All 12 patients in DIAGNODE-1, an open clinical pilot trial, where the diabetes vaccine Diamyd® is given directly into the lymph node, have now completed their 6-month visit. The database was locked today and the data analysis process can thus begin. Preliminary results will be reported before Christmas. About DIAGNODE-1DIAGNODE-1 is an open label pilot trial, comprising a total of twelve patients between the ages of 12 and 30 with type 1 diabetes, where a low dose of the diabetes vaccine Diamyd® is administered directly into the lymph node in combination with treatment with vitamin D.